Literature DB >> 10391856

Effects of amphetamine on development of oral candidiasis in rats.

M Freire-Garabal1, M J Núñez, J Balboa, A Rodríguez-Cobo, J M López-Paz, M Rey-Méndez, J A Suárez-Quintanilla, J C Millán, J M Mayán.   

Abstract

Experiments were conducted to evaluate the effects of amphetamine (0. 4 mg/kg of body weight/day) on the development of oral candidiasis in Sprague-Dawley rats. Animals were submitted to surgical hyposalivation in order to facilitate the establishment and persistence of Candida albicans infection. Treatment with drugs (placebo or amphetamine) was initiated 7 days before C. albicans inoculation and lasted until the end of the experiments, day 15 postinoculation. Establishment of C. albicans infection was evaluated by swabbing the inoculated oral cavity with a sterile cotton applicator on days 2 and 15 after inoculation, followed by plating on YEPD (yeast extract-peptone-dextrose) agar. Tissue injury was determined by the quantification of the number and type (normal or abnormal) of papillae on the dorsal tongue per microscopic field. A semiquantitative scale was devised to assess the degree of colonization of the epithelium by fungal hyphae. Our results show that amphetamine exacerbates C. albicans infection of the tongues of rats. Significant increases in Candida counts, the percentage of the tongue's surface covered with clinical lesions, the percentage of abnormal papillae, and the colonization of the epithelium by fungal hyphae were found in amphetamine-treated rats compared to those found in the rats injected with a placebo. The last two parameters increased in rats treated with the placebo compared to the parameters of the untreated control rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391856      PMCID: PMC95721          DOI: 10.1128/CDLI.6.4.530-533.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  27 in total

1.  A combination rapid and standard method for identification of Candida albicans.

Authors:  G Schaar; I Long; A Widra
Journal:  Mycopathol Mycol Appl       Date:  1974-04-30

2.  Corticotropin releasing factor produces behavioural activation in rats.

Authors:  R E Sutton; G F Koob; M Le Moal; J Rivier; W Vale
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

3.  Chronic candidiasis of the rat tongue: a possible model for human median rhomboid glossitis.

Authors:  C M Allen; G G Blozis; S Rosen; J S Bright
Journal:  J Dent Res       Date:  1982-11       Impact factor: 6.116

4.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

5.  Interchangeability of stress and amphetamine in sensitization.

Authors:  S M Antelman; A J Eichler; C A Black; D Kocan
Journal:  Science       Date:  1980-01-18       Impact factor: 47.728

6.  The effect of desalivation on coronal and root surface caries in rats.

Authors:  W H Bowen; S K Pearson; D A Young
Journal:  J Dent Res       Date:  1988-01       Impact factor: 6.116

Review 7.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

8.  Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi.

Authors:  M S Cohen; R E Isturiz; H L Malech; R K Root; C M Wilfert; L Gutman; R H Buckley
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

9.  Effects of amphetamine on cell mediated immune response in mice.

Authors:  M J Núñez-Iglesias; C Castro-Bolaño; C Losada; M D Pereiro-Raposo; P Riveiro; P Sánchez-Sebio; J M Mayán-Santos; M Rey-Méndez; M Freire-Garabal
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

10.  Psychoneuroendocrine influences on immunocompetence and neoplasia.

Authors:  V Riley
Journal:  Science       Date:  1981-06-05       Impact factor: 47.728

View more
  7 in total

1.  Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.

Authors:  A Martinez; J Regadera; E Jimenez; I Santos; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 2.  Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?

Authors:  Noreen T Boyle; Thomas J Connor
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

3.  Effects of psychological stress and fluoxetine on development of oral candidiasis in rats.

Authors:  María J Núñez; Silvia Novío; Juan Antonio Suárez; José Balboa; Manuel Freire-Garabal
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

4.  Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method.

Authors:  Parastoo Hassani Abharian; Parvin Dehghan; Peyman Hassani-Abharian; Zahra Jabalameli
Journal:  Adv Biomed Res       Date:  2020-07-27

5.  Effects of psychological stress and alprazolam on development of oral candidiasis in rats.

Authors:  M J Núñez; J Balboa; P Riveiro; D Liñares; P Mañá; M Rey-Méndez; A Rodríguez-Cobos; J A Suárez-Quintanilla; L A García-Vallejo; M Freire-Garabal
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

6.  Biological assessment of ozone therapy on experimental oral candidiasis in immunosuppressed rats.

Authors:  Laila E Amin
Journal:  Biochem Biophys Rep       Date:  2018-07-11

7.  Prolonged Peripheral Immunosuppressive Responses as Consequences of Random Amphetamine Treatment, Amphetamine Withdrawal and Subsequent Amphetamine Challenges in Rats.

Authors:  Wojciech Glac; Joanna Dunacka; Beata Grembecka; Grzegorz Świątek; Irena Majkutewicz; Danuta Wrona
Journal:  J Neuroimmune Pharmacol       Date:  2021-02-13       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.